A Net Benefit Approach for the Optimal Allocation of a COVID-19 Vaccine

Erin Kirwin, Ellen Rafferty, Kate Harback, Jeff Round, Christopher McCabe
doi: https://doi.org/10.1101/2020.11.30.20240986

Article Information

doi 
https://doi.org/10.1101/2020.11.30.20240986
History 
  • May 10, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Erin Kirwin, MA1,2,*,
  2. Ellen Rafferty, PhD1,
  3. Kate Harback, PhD1,
  4. Jeff Round, PhD1,3 and
  5. Christopher McCabe, PhD1,4
  1. 1Institute of Health Economics, Edmonton, Alberta, Canada
  2. 2Health Organisation, Policy, and Economics, School of Health Sciences, University of Manchester, United Kingdom
  3. 3School of Public Health, University of Alberta, Edmonton, Alberta, Canada
  4. 4Department of Emergency Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
  1. ↵*Corresponding author. EKirwin{at}ihe.ca, Institute of Health Economics #1200, 10405 Jasper Avenue Edmonton, AB, Canada T5J 3N4
Back to top
Posted May 10, 2021.
Download PDF

Supplementary Material

Data/Code
Email
A Net Benefit Approach for the Optimal Allocation of a COVID-19 Vaccine
Erin Kirwin, Ellen Rafferty, Kate Harback, Jeff Round, Christopher McCabe
medRxiv 2020.11.30.20240986; doi: https://doi.org/10.1101/2020.11.30.20240986
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area